Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS Core MSCI EM UCITS ETF USD dis
LU0480132876 · LU0480132876 · USD · domicile Luxembourg
Equity · Emerging marketsSFDR art. 6
Index tracked: MSCI Emerging Markets Total Return Net
- TER
- 0.15%+ trans. 0.01%
- Fund size
- 2.5 bn EUR
- Tracking difference
- +0.06%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical (mixed: optimised/sampled)
- Income
- Distributingsemi-annual
Launch 12 Nov 2010 · costs from the KID as of 2 Sept 2026 · 0 securities held · 10 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 5 Aug 2026
The Fund is passively managed and will take proportionate exposure on the components of the MSCI Emerging Markets Index (Net Return) using a sampling strategy which invests in a representative sample of constituent stocks of the index selected by the investment manager using quantitative analytical models in a technique known as 'portfolio optimization'. The sub-fund can also make use of derivatives in particular where it may not be possible or practicable to replicate the index through direct investments or in order to generate efficiencies in gaining…
Performance since series start (in euro) — base 100
12 Nov 2010 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +41.0% |
| 3 years | +77.5% |
| 5 years | +52.7% |
| 10 years | +128.4% |
| Since series start | +154.9% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 23.09% | 17.86% | 17.77% |
| Max drawdown | −13.45% | −16.65% | −35.70% |
| Sharpe | 1.38 | 1.01 | 0.28 |
| Sortino | 2.07 | 1.45 | 0.40 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU0480132876 · LU04801328761
RebalixLU0480132876 · LU0480132876 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +33.85% | +33.57% | +0.28% |
| 2024 | +7.68% | +7.50% | +0.17% |
| 2023 | +9.57% | +9.83% | −0.26% |
| 2022 | −19.94% | −20.09% | +0.15% |
| 2021 | −2.99% | −2.38% | −0.61% |
Distributions · per share, in USD
Frequency: semi-annual · last 12 months: 2.8537 USD (1.64% of NAV) · last ex-date 13 Aug 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 2.8537 | — |
| 2025 | 2 | 3.0199 | +2.82% |
| 2024 | 2 | 2.3218 | +2.28% |
| 2023 | 2 | 2.6429 | +2.77% |
| 2022 | 2 | 2.7821 | +2.28% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 31 Jul 2026 · 0 securities · top-10 weight = 38.9%
| Top holdings | Weight |
|---|---|
| 15.5% | |
| 8.1% | |
| 5.6% | |
| 3.1% | |
| 2.1% | |
| 1.3% | |
| 0.8% | |
| 0.8% | |
| 0.8% | |
| 0.8% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
EMMEUA · Borsa Italiana (ETFplus)
UIMI · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Euronext Amsterdam, Tradegate Exchange, Xetra (Deutsche Börse)
+ 16 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
Prospectus · www.ubs.com/2/e/files/lux_etf_pe.pdf
The live sheet, always up to date
rebalix.com/en/etf/LU0480132876
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU0480132876
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · LU0480132876 · LU04801328762